Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

Sokol M., Zenin V., Yabbarov N., Mollaev M., Zabolotsky A., Mollaeva M., Fomicheva M., Kuznetsov S., Popenko V., Seregina I., Nikolskaya E.
Тип документаJournal Article
Дата публикации2021-09-25
Название журналаAnnales Pharmaceutiques Francaises
ИздательElsevier
Квартиль по SCImagoQ3
Квартиль по Web of Science
Импакт-фактор 2021
ISSN00034509
Pharmacology
Pharmaceutical Science
Пристатейные ссылки: 18
Цитируется в публикациях: 1
Development and validation of RP-HPLC method for simultaneous estimation of docetaxel and ritonavir in PLGA nanoparticles.
Kumbhar P.S., Diwate S.K., Mali U.G., Shinde T.U., Disouza J.I., Manjappa A.S.
Q3 Annales Pharmaceutiques Francaises 2020 цитирований: 5
Development of novel PLGA nanoparticles with co‐encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells
Sokol M.B., Nikolskaya E.D., Yabbarov N.G., Zenin V.A., Faustova M.R., Belov A.V., Zhunina O.A., Mollaev M.D., Zabolotsky A.I., Tereshchenko O.G., Severin E.S.
Q2 Journal of Biomedical Materials Research - Part B Applied Biomaterials 2018 цитирований: 26
Current development in the formulations of non‐injection administration of paclitaxel
Du X., Khan A.R., Fu M., Ji J., Yu A., Zhai G.
Q1 International Journal of Pharmaceutics 2018 цитирований: 27
Open Access
Open access
Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency
Zhang Z., Wang X., Li B., Hou Y., Cai Z., Yang J., Li Y.
Q1 RSC Advances 2018 цитирований: 29
Open Access
Open access
Alpha-fetoprotein: A fabulous biomarker in hepatocellular, gastric and rectal cancer diagnosis
Naz Z., Usman S., Saleem K., Ahmed S., Bashir H., Bilal M., Sumrin A.
Q3 Biomedical Research 2018 цитирований: 12
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF PACLITAXEL IN PHARMACEUTICAL DOSAGE FORMS
Suman P.
World Journal of Pharmacy and Pharmaceutical Sciences 2017 цитирований: 1
The docetaxel polymeric form and its antitumor activity
Nikolskaya E.D., Zhunina O.A., Yabbarov N.G., Tereshchenko O.G., Godovannyy A.V., Gukasova N.V., Severin E.S.
Q4 Russian Journal of Bioorganic Chemistry 2017 цитирований: 4
Development and validation of a reversed‐phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers
Furman C., Carpentier R., Barczyk A., Chavatte P., Betbeder D., Lipka E.
Q2 Electrophoresis 2017 цитирований: 6
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Kampan N.C., Madondo M.T., McNally O.M., Quinn M., Plebanski M.
Q2 BioMed Research International 2015 цитирований: 119
Open Access
Open access
How Taxol/paclitaxel kills cancer cells
Weaver B.A.
Q1 Molecular Biology of the Cell 2014 цитирований: 587
Development and validation of RP-HPLC method: scope of application in the determination of oil solubility of paclitaxel.
Choudhury H., Gorain B., Karmakar S., Pal T.K.
Q3 Journal of Chromatographic Science 2013 цитирований: 26
Isolation and characterization of the recombinant human α-fetoprotein fragment corresponding to the C-terminal structural domain
Sharapova O.A., Pozdnyakova N.V., Laurinavichyute D.K., Yurkova M.S., Posypanova G.A., Andronova S.M., Fedorov A.N., Severin S.E., Severin E.S.
Q4 Russian Journal of Bioorganic Chemistry 2010 цитирований: 3
PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches.
Hung L., Teh S., Jester J., Lee A.P.
Q1 Lab on a Chip 2010 цитирований: 117
Метрики
Поделиться
Цитировать
ГОСТ |
Цитировать
1. Sokol M. и др. Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study // Annales Pharmaceutiques Françaises. 2021. Т. 79. № 5. С. 500–510.
RIS |
Цитировать

TY - JOUR

DO - 10.1016/j.pharma.2021.02.001

UR - http://dx.doi.org/10.1016/j.pharma.2021.02.001

TI - Validated HPLC method for paclitaxel determination in PLGA submicron particles conjugated with α-fetoprotein third domain: Sample preparation case study

T2 - Annales Pharmaceutiques Françaises

AU - Sokol, M.

AU - Zenin, V.

AU - Yabbarov, N.

AU - Mollaev, M.

AU - Zabolotsky, A.

AU - Mollaeva, M.

AU - Fomicheva, M.

AU - Kuznetsov, S.

AU - Popenko, V.

AU - Seregina, I.

AU - Nikolskaya, E.

PY - 2021

DA - 2021/09

PB - Elsevier BV

SP - 500-510

IS - 5

VL - 79

SN - 0003-4509

ER -

BibTex |
Цитировать

@article{Sokol_2021,

doi = {10.1016/j.pharma.2021.02.001},

url = {https://doi.org/10.1016%2Fj.pharma.2021.02.001},

year = 2021,

month = {sep},

publisher = {Elsevier {BV}},

volume = {79},

number = {5},

pages = {500--510},

author = {M. Sokol and V. Zenin and N. Yabbarov and M. Mollaev and A. Zabolotsky and M. Mollaeva and M. Fomicheva and S. Kuznetsov and V. Popenko and I. Seregina and E. Nikolskaya},

title = {Validated {HPLC} method for paclitaxel determination in {PLGA} submicron particles conjugated with $\upalpha$-fetoprotein third domain: Sample preparation case study},

journal = {Annales Pharmaceutiques Fran{\c{c}}aises}

}

MLA
Цитировать
Sokol, M., et al. “Validated HPLC Method for Paclitaxel Determination in PLGA Submicron Particles Conjugated with α-Fetoprotein Third Domain: Sample Preparation Case Study.” Annales Pharmaceutiques Françaises, vol. 79, no. 5, Sept. 2021, pp. 500–10. Crossref, https://doi.org/10.1016/j.pharma.2021.02.001.